Roman Wölfel

ORCID: 0000-0002-8756-7821
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • Viral Infections and Vectors
  • SARS-CoV-2 detection and testing
  • Viral Infections and Outbreaks Research
  • COVID-19 Clinical Research Studies
  • Vector-Borne Animal Diseases
  • COVID-19 epidemiological studies
  • Bacteriophages and microbial interactions
  • Bacillus and Francisella bacterial research
  • Vector-borne infectious diseases
  • Biosensors and Analytical Detection
  • Animal Virus Infections Studies
  • Fire effects on ecosystems
  • Disaster Response and Management
  • Yersinia bacterium, plague, ectoparasites research
  • Mosquito-borne diseases and control
  • Herpesvirus Infections and Treatments
  • Poxvirus research and outbreaks
  • Viral gastroenteritis research and epidemiology
  • vaccines and immunoinformatics approaches
  • Virus-based gene therapy research
  • Microbial infections and disease research
  • Zoonotic diseases and public health
  • Hepatitis B Virus Studies
  • Advanced biosensing and bioanalysis techniques

German Center for Infection Research
2013-2025

Czech Academy of Sciences, Institute of Microbiology
2006-2024

Institut für Mikrobiologie der Bundeswehr
2015-2024

Universität der Bundeswehr München
2015-2024

Military Hospital of Tunis
2021

Mali-Folkecenter
2019

European Molecular Biology Laboratory
2014-2019

Bernhard Nocht Institute for Tropical Medicine
2007-2016

Bundeswehr Medical Service Academy
2012-2015

Walter Reed Army Institute of Research
2014

Joshua Quick Nicholas J. Loman Sophie Duraffour Jared T. Simpson Ettore Severi and 95 more Lauren A. Cowley Joseph Akoi Boré Raymond Koundouno Gytis Dudas Amy Mikhail Nobila Ouédraogo Babak Afrough Amadou Bah Jonathan H. J. Baum Beate Becker‐Ziaja Jan Peter Boettcher Mar Cabeza-Cabrerizo Álvaro Camino-Sánchez Lisa L. Carter Juliane Doerrbecker Theresa Enkirch Isabel García-Dorival Nicole Hetzelt Julia Hinzmann Tobias Holm Liana E. Kafetzopoulou Michel Koropogui Abigael Kosgey Eeva Kuisma Christopher H. Logue Antonio Mazzarelli Sarah Meisel Marc Mertens Janine Michel Didier Ngabo Katja Nitzsche Elisa Pallasch Livia Victoria Patrono Jasmine Portmann Johanna Repits Natasha Y. Rickett Andreas Sachse Katrin Singethan Inês Vitoriano Rahel L. Yemanaberhan Elsa Gayle Zekeng Trina Racine Alexander Bello Amadou Alpha Sall Ousmane Faye Oumar Faye N’Faly Magassouba C.V. Williams Victoria Amburgey Linda Winona Emily Davis Jon Gerlach F Clarke -Washington Vanessa Monteil Marine Jourdain Marion Bererd Alimou Camara Hermann Somlaré Abdoulaye Camara Marianne Gérard Guillaume Bado Bernard Baillet D. Delaune Koumpingnin Nebié Abdoulaye Diarra Yacouba Savane Raymond Pallawo Giovanna Jaramillo Gutierrez Natacha Milhano Isabelle Roger Christopher J. Williams Facinet Yattara Kuiama Lewandowski James G. Taylor Phillip A. Rachwal Daniel J. Turner Georgios Pollakis Julian A. Hiscox David A. Matthews Matthew K. O’ Shea Andrew Johnston Duncan Wilson Emma Hutley Erasmus Smit Antonino Di Roman Wölfel Kilian Stoecker Erna Fleischmann Martin Gabriel Simon A. Weller Lamine Koivogui Boubacar Diallo Sakoba Keïta Andrew Rambaut Pierre Formenty

10.1038/nature16996 article EN Nature 2016-02-01

In December, 2019, the newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, causing COVID-19, a disease presenting with fever, cough, and often pneumonia. WHO has set strategic objective to interrupt spread of SARS-CoV-2 worldwide. An outbreak Bavaria, Germany, starting at end January, 2020, provided opportunity study transmission events, incubation period, secondary attack rates.

10.1016/s1473-3099(20)30314-5 article EN other-oa The Lancet Infectious Diseases 2020-05-16
Daouda Sissoko Cédric Laouénan Elin Folkesson Abdoul-Bing M’Lebing Abdoul-Habib Beavogui and 95 more Sylvain Baize Alseny-Modet Camara Piet Maes Susan Shepherd Christine Danel Sara Carazo Mamoudou N. Conde Jean‐Luc Gala Géraldine Colin Hélène Savini Joseph Akoi Boré Frédéric Le Marcis Fara Raymond Koundouno Frédéric Petitjean Marie-Claire Lamah Sandra Diederich Alexis Tounkara Geertrui Poelart Emmanuel Berbain Jean-Michel Dindart Sophie Duraffour Annabelle Lefevre Tamba Leno Olivier Peyrouset Léonid M. Irenge N’Famara Bangoura Romain Palich Julia Hinzmann Annette Kraus Thierno Sadou Barry Sakoba Berette André Bongono Mohamed Seto Camara Valérie Chanfreau Munoz Lanciné Doumbouya Souley Harouna Patient Mumbere Kighoma Fara Roger Koundouno Réné Lolamou Cécé Moriba Loua Vincent Massala Moumouni Kinda Célia Provost Nenefing Samake Conde Sekou Abdoulaye Soumah Isabelle Arnould Michel Saa Komano Lina Gustin Carlotta Berutto Diarra Camara Fodé Saydou Camara Joliene Colpaert Léontine Delamou Lena Jansson Etienne Kourouma Maurice Loua Kristian Nødtvedt Malme Emma Manfrin André Maomou Adele Milinouno Sien Ombelet Aboubacar Youla Sidiboun Isabelle Verreckt Pauline Yombouno Anne Bocquin Caroline Carbonnelle T. Carmoi Pierre Frange Stéphane Mély Vinh‐Kim Nguyen Delphine Pannetier Anne‐Marie Taburet Jean‐Marc Tréluyer Jacques Séraphin Kolié Raoul Moh Minerva Cervantes Gonzalez Eeva Kuisma Britta Liedigk Didier Ngabo Martin Rudolf Ruth Thom Romy Kerber Martin Gabriel Antonino Di Roman Wölfel Jamal Badir Mostafa Bentahir Yann Deccache Catherine Dumont F. Durant Karim El Bakkouri Marie Gasasira Uwamahoro Benjamin Smits Nora Toufik

Ebola virus disease (EVD) is a highly lethal condition for which no specific treatment has proven efficacy. In September 2014, while the outbreak was at its peak, World Health Organization released short list of drugs suitable EVD research. Favipiravir, an antiviral developed severe influenza, one these. late conditions starting randomized trial were not fulfilled two reasons. One perception that, given high number patients presenting simultaneously and very mortality rate disease, it...

10.1371/journal.pmed.1001967 article EN cc-by PLoS Medicine 2016-03-01

Coronavirus disease 2019 (COVID-19) is an acute respiratory tract infection that emerged in late 1,2 . Initial outbreaks China involved 13.8% cases with severe-, and 6.1% critical courses 3 This severe presentation corresponds to the usage of a virus receptor expressed predominantly lung 2,4 By causing early onset symptoms, this same tropism thought have determined pathogenicity but also aided control syndrome (SARS) 2003 5 However, there are reports COVID-19 mild upper suggesting potential...

10.1101/2020.03.05.20030502 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2020-03-08
Gytis Dudas Luiz Max Carvalho Trevor Bedford Andrew J. Tatem Guy Baele and 91 more Nuno R. Faria Daniel J. Park Jason T. Ladner Armando Arias Danny Asogun Filip Bielejec Sarah Caddy Matthew Cotten Jonathan D’ambrozio Simon Dellicour Antonino Di Joseph W. Diclaro Sophie Duraffour Michael J. Elmore Lawrence Fakoli Ousmane Faye Merle L. Gilbert Sahr M. Gevao Stephen Gire Adrianne Gladden-Young Andreas Gnirke Augustine Goba Donald S. Grant Bart L. Haagmans Julian A. Hiscox Umaru Jah Jeffrey R. Kugelman Di Liu Jia Lu Christine M. Malboeuf Suzanne Mate David A. Matthews Christian B. Matranga Luke W. Meredith James Qu Joshua Quick Suzan D. Pas My V. T. Phan Georgios Pollakis Chantal Reusken Mariano Sánchez-Lockhart S. F. Schaffner John S. Schieffelin Rachel Sealfon Etienne Simon‐Lorière Saskia L. Smits Kilian Stoecker Lucy Thorne Ekaete Tobin Mohamed Vandi Simon J. Watson Kendra West Shannon Whitmer Michael R. Wiley S Winnicki Shirlee Wohl Roman Wölfel Nathan L. Yozwiak Kristian G. Andersen Sylvia O. Blyden Fatorma K. Bolay Miles W. Carroll Bernice Dahn Boubacar Diallo Pierre Formenty Christophe Fraser George F. Gao Robert F. Garry Ian Goodfellow Stephan Günther Christian T. Happi Edward C. Holmes Brima Kargbo Alpha Kabinet Keïta Paul Kellam Marion Koopmans Jens H. Kuhn Nicholas J. Loman N’Faly Magassouba Dhamari Naidoo Stuart T. Nichol Tolbert Nyenswah Gustavo Palacios Oliver G. Pybus Pardis C. Sabeti Amadou A. Sall Ute Ströher Isatta Wurie Marc A. Suchard Philippe Lemey Andrew Rambaut

10.1038/nature22040 article EN Nature 2017-04-01

Abstract Crimean-Congo hemorrhagic fever (CCHF) is a highly contagious viral tick-borne disease with case-fatality rates as high 50%. We describe collaborative evaluation of the characteristics, performance, and on-site applicability serologic molecular assays for diagnosis CCHF. evaluated ELISA, immunofluorescence, quantitative reverse transcription PCR, low-density macroarray detection CCHF virus using precharacterized archived patient serum samples. Compared results local, in-house...

10.3201/eid1812.120710 article EN cc-by Emerging infectious diseases 2012-10-29

10.1038/nature17949 article EN Nature 2016-05-03

Abstract Background Monkeypox is a zoonotic orthopoxvirus infection endemic in central and western Africa. In May 2022, human monkeypox infections including human-to-human transmission were reported multi-country outbreak Europe North America. Case presentations Here we present the first two cases of humans diagnosed Germany. We clinical virological findings, detection virus DNA blood semen. The presentation medical history our patients suggest close physical contact during sexual...

10.1007/s15010-022-01874-z article EN cc-by Infection 2022-07-11

To end the largest known outbreak of Ebola virus disease (EVD) in West Africa and to prevent new transmissions, rapid epidemiological tracing cases contacts was required. The ability quickly identify unknown sources chains transmission is key ending EVD epidemic even greater importance context recent reports (EBOV) persistence survivors. Phylogenetic analysis complete EBOV genomes can provide important information on source any infection. A local deep sequencing facility established at...

10.1093/ve/vew016 article EN cc-by-nc Virus Evolution 2016-01-01

Summary The global emergence of SARS-CoV-2 urgently requires an in-depth understanding molecular functions viral proteins and their interactions with the host proteome. Several individual omics studies have extended our knowledge COVID-19 pathophysiology 1–10 . Integration such datasets to obtain a holistic view virus-host define pathogenic properties is limited by heterogeneity experimental systems. We therefore conducted concurrent multi-omics study SARS-CoV. Using state-of-the-art...

10.1101/2020.06.17.156455 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2020-06-17

By January, 2016, all known transmission chains of the Ebola virus disease (EVD) outbreak in west Africa had been stopped. However, there is concern about persistence reproductive tract men who have survived EVD. We aimed to use biostatistical modelling describe dynamics RNA load seminal fluid, including clearance parameters.In this longitudinal study, we recruited discharged from three treatment units Guinea between January and July, 2015. Participants provided samples fluid at follow-up...

10.1016/s2214-109x(16)30243-1 article EN cc-by The Lancet Global Health 2016-12-10
Raquel Rubio‐Acero Noemi Castelletti Volker Fingerle Laura Olbrich Abhishek Bakuli and 95 more Roman Wölfel Philipp Girl Katharina Müller Simon Jochum Matthias Strobl Michael Höelscher Andreas Wieser Emad Alamoudi Jared L. Anderson Valeria Baldassare Maximilian Baumann Marieke Behlen Marc Becker Jessica Beyerl Rebecca Böhnlein Isabel Brand Anna Brauer Vera Britz Jan Bruger Friedrich Caroli Lorenzo Contento Alina Czwienzek Flora Deák Emma Dech Laura Dech Maximilian N. Diefenbach Jana Diekmannshemke Anna Do Gerhard Dobler Ute Eberle Juergen Durner Ute Eberle Judith Eckstein Tabea M. Eser Philine Falk Jonathan Frese Stefanie Fischer Felix Forster Turid Frahnow Jonathan Frese Günter Fröschl Christiane Fuchs Mercè Garí Marius Gasser Sonja Gauder Otto Geisenberger Christof Geldmacher Kristina Gillig Elias Golschan Vitus Grauvogl Jessica Michelle Guggenbüehl Noller Celina Halfmann Tim Haselwarter Jan Hasenauer Arlett Heiber Matthias Herrmann Stefan Hillmann Christian Hinske Janna Hoefflin Tim Hofberger Michael Höfinger Larissa Hoffmann Sacha Horn Kristina Huber Christian Janke Ursula Kappl Charlotte Kiani Isabel Klugherz Norah Kreider Inge Kroidl Arne Kroidl Magdalena Lang Clemens Lang Silvan Lange Ekaterina Lapteva Michael Laxy Ronan Le Gleut Reiner Leidl Felix Lindner Alexander Maczka Alicia Markgraf Paula Matcau Rebecca Mayrhofer Anna‐Maria Mekota Katharina Müller Dafni Metaxa Leonie Pattard Ivana Paunović Claire Pleimelding Michel Pletschette Michael Pritsch Stephan Prückner Kerstin Puchinger Konstantin Pusl Peter Pütz

Quantitative serological assays detecting response to SARS-CoV-2 are needed quantify immunity. This study analyzed the performance and correlation of two quantitative anti-S1 in oligo-/asymptomatic individuals from a population-based cohort.In total, 362 plasma samples (108 with reverse transcription-polymerase chain reaction [RT-PCR]-positive pharyngeal swabs, 111 negative controls, 143 positive serology without confirmation by RT-PCR) were tested (Euroimmun Anti-SARS-CoV-2 QuantiVac...

10.1007/s40121-021-00475-x article EN cc-by-nc Infectious Diseases and Therapy 2021-06-16

Given the large number of mild or asymptomatic SARS-CoV-2 cases, only population-based studies can provide reliable estimates magnitude pandemic. We therefore aimed to assess sero-prevalence in Munich general population after first wave For this purpose, we drew a representative sample 2994 private households and invited household members 14 years older complete questionnaires blood samples. seropositivity was defined as Roche N pan-Ig ≥ 0.4218. adjusted prevalence for sampling design,...

10.3390/ijerph18073572 article EN International Journal of Environmental Research and Public Health 2021-03-30

Neutrophils are key players during host defense and sterile inflammation. Neutrophil dysfunction is a characteristic feature of the acquired immunodeficiency kidney disease. We speculated that impaired renal clearance intrinsic purine metabolite soluble uric acid (sUA) may account for neutrophil dysfunction. Indeed, hyperuricemia (HU, serum UA 9-12 mg/dL) related or unrelated to significantly diminished adhesion extravasation in mice with crystal- coronavirus-related inflammation using...

10.1182/blood.2021011234 article EN cc-by-nc-nd Blood 2022-03-18

SARS-CoV-2 infection is accompanied by elevated liver enzymes, and patients with pre-existing conditions experience more severe disease. While it was known that infects human hepatocytes, our study determines the mechanism of infection, demonstrates viral replication spread, highlights direct hepatocyte damage. Viral readily detectable upon primary hepatocytes hepatoma cells ancestral SARS-CoV-2, Delta, Omicron variants. Hepatocytes express receptor ACE2 host cell protease TMPRSS2, knocking...

10.1002/jmv.70156 article EN cc-by-nc-nd Journal of Medical Virology 2025-01-01

Abstract We developed a real-time reverse transcription–-PCR that detected 1,164 copies/mL of Crimean-Congo hemorrhagic fever virus per milliliter serum at 95% probability (probit analysis) and was 100% concordant with nested PCR on 63 samples from 31 patients confirmed infection. Infected who died appeared to have higher viral loads; low loads correlated IgG detection.

10.3201/eid1307.070068 article EN cc-by Emerging infectious diseases 2007-07-01

Background Whole genome sequencing allowed the development of a number high resolution sequence based typing tools for Yersinia (Y.) pestis. The application these methods on isolates from most known foci worldwide and in particular China Former Soviet Union has dramatically improved our understanding population structure this species. In current view, Y. pestis including non or moderate human pathogen subspecies microtus emerged pseudotuberculosis about 2,600 to 28,600 years ago central...

10.1371/journal.pone.0030624 article EN cc-by PLoS ONE 2012-02-17

Containment strategies and clinical management of coronavirus disease (COVID-19) patients during the current pandemic depend on reliable diagnostic PCR assays for severe acute respiratory syndrome 2 (SARS-CoV-2). Here, we compare 11 different RT-PCR test systems used in seven laboratories Germany March 2020. While most performed well, identified detection problems a commonly assay that may have resulted false-negative results first weeks pandemic.

10.2807/1560-7917.es.2020.25.24.2001057 article EN cc-by Eurosurveillance 2020-06-18

Abstract Prolonged shedding of infectious SARS-CoV-2 has recently been reported in a number immunosuppressed individuals with COVID-19. Here, we describe the detection high levels replication-competent specimens taken from respiratory tract B-cell depleted patient up to 154 days after initial COVID-19 diagnosis concomitant development mutation rate. In this patient, total 11 nonsynonymous mutations were detected addition Y144 deletion spike protein SARS-CoV-2. Virus evolution studies...

10.1101/2021.01.10.20248871 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-01-15
Coming Soon ...